Discontinued — last reported Q3 '24
Other
Stock Issued During Period, Value, Deferred Payments For Acquisitions
Insmed Stock Issued During Period, Value, Deferred Payments For Acquisitions increased by 261.4% to $14.08M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 261.4%, from $3.90M to $14.08M.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2022
Last reportedQ3 2024Oct 30, 2025
How to read this metric
Higher values indicate the settlement of acquisition-related liabilities using equity, preserving cash.
Detailed definition
The value of common stock issued to satisfy deferred or contingent consideration obligations related to past business ac...
Peer comparison
Common for acquisitive companies using stock as acquisition currency.
Metric ID:
other_stock_issued_during_period_value_deferred_payments_62a6eaHistorical Data
6 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q3 '24 | |
|---|---|---|---|---|---|---|
| Value | $1.07M | $1.07M | $1.07M | $1.07M | $3.90M | $14.08M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +262.8% | +261.4% |
| YoY Change | — | — | — | — | +262.8% | +261.4% |
Range$1.07M – $14.08M
CAGR+683.7%
Avg YoY Growth+262.1%
Median YoY Growth+262.1%
Current Streak5+ quarters growth
Stock Issued During Period, Value, Deferred Payments For Acquisitions at Other Companies
Frequently Asked Questions
- What is Insmed's stock issued during period, value, deferred payments for acquisitions?
- Insmed (INSM) reported stock issued during period, value, deferred payments for acquisitions of $14.08M in Q3 2024.
- How has Insmed's stock issued during period, value, deferred payments for acquisitions changed year-over-year?
- Insmed's stock issued during period, value, deferred payments for acquisitions increased by 261.4% year-over-year, from $3.90M to $14.08M.
- What does stock issued during period, value, deferred payments for acquisitions mean?
- Shares issued to pay for previous business acquisitions.